Trial NCT02767752

View at ClinicalTrials.gov 
Org. Study IDs: GI 1604

Last trial update was posted on 2018-07-10

MeSH Interventions

Capecitabine Gemcitabine

MeSH Conditions

Pancreatic Neoplasms

Other Conditions

Pancreatic Cancer

Stopping Reasons

Poor accrual and change of SOC (FOLFIRINOX in adjuvant setting)

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID